Fondaparinux versus enoxaparin for prevention of venous thromboembolism [4] (multiple letters)

Lancet

Volumn 360, Issue 9345, 2002, Pages 1603-1604

  Borja, Javier ^a   Olivella, Pere ^a   Curto, Jorge ^a   Thaler, Heinrich ^b   Sim, Ernst ^b   Morris, Edward ^c   Lassen, M R ^d,e   Turpie, A G G ^d,e  

^a Pharmacia Spain   (Spain)

^b Unfallkrankenhaus Meidling   (Austria)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

^d University Hospital of Copenhagen ^*  (Denmark)

^e HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FONDAPARINUX; HEPARIN; PLACEBO;

BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; HIP SURGERY; HUMAN; LETTER; META ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; RISK; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; VEIN;

EID: 0037121244     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(02)11542-x     Document Type: Letter

References (0)